Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Return on Assets (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Return on Assets for 15 consecutive years, with 0.92% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets fell 21.0% to 0.92% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.92%, a 21.0% decrease, with the full-year FY2024 number at 0.63%, down 28.0% from a year prior.
  • Return on Assets was 0.92% for Q3 2025 at Creative Medical Technology Holdings, down from 0.75% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 2.67% in Q4 2021 to a low of 16.57% in Q2 2021.
  • A 5-year average of 2.48% and a median of 0.71% in 2024 define the central range for Return on Assets.
  • Biggest YoY gain for Return on Assets was 6623bps in 2021; the steepest drop was -735bps in 2021.
  • Creative Medical Technology Holdings' Return on Assets stood at 2.67% in 2021, then plummeted by -118bps to 0.49% in 2022, then increased by 7bps to 0.46% in 2023, then plummeted by -78bps to 0.81% in 2024, then decreased by -14bps to 0.92% in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Return on Assets are 0.92% (Q3 2025), 0.75% (Q2 2025), and 0.81% (Q1 2025).